图书馆订阅: Guest
真核基因表达评论综述™

每年出版 6 

ISSN 打印: 1045-4403

ISSN 在线: 2162-6502

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.6 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.2 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.3 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00058 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.33 SJR: 0.345 SNIP: 0.46 CiteScore™:: 2.5 H-Index: 67

Indexed in

Cancer Treatment-Related Bone Disease

卷 19, 册 1, 2009, pp. 47-60
DOI: 10.1615/CritRevEukarGeneExpr.v19.i1.20
Get accessGet access

摘要

Bone health may be impaired in many patients being treated for cancer. Primary tumors that reside in or form metastases to bone can result in compromised skeletal integrity. It has also been increasingly recognized that patients undergoing therapies for treatment of cancer are at higher risk of bone loss. These include androgen-deprivation therapy for prostate cancer and aromatase inhibitor therapy for breast cancer, among others. Hypogonadism induced by many of these cancer treatments results in bone loss and increases the risk of osteoporosis and fractures. Progress has been made in identifying the role of oral and intravenous bisphosphonates to prevent bone loss in these patients. This review discusses bone loss associated with cancer treatments, with a focus on breast cancer, prostate cancer, and survivors of childhood malignancies.

对本文的引用
  1. Acu K., Scheel M., Issever A. S., Time dependency of bone density estimation from computed tomography with intravenous contrast agent administration, Osteoporosis International, 25, 2, 2014. Crossref

  2. Willey Jeffrey S., Lloyd Shane A.J., Bateman Ted A., Radiation Therapy-Induced Osteoporosis, in Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 2013. Crossref

  3. Choi Kyung-Hyun, Park Sang Min, Park Joo-Sung, Park Jae-Hyun, Kim Kyae Hyung, Kim Myung-Ju, Prevalence of and Factors Associated with Osteoporosis among Korean Cancer Survivors: A Cross-Sectional Analysis of the Fourth and Fifth Korea National Health and Nutrition Examination Surveys, Asian Pacific Journal of Cancer Prevention, 14, 8, 2013. Crossref

  4. Kelly D. L., Myers C. S., Abrams M. T., Feldman S., Park J., McMahon R. P., Shim J.-C., The impact of substance abuse on osteoporosis screening and risk of osteoporosis in women with psychotic disorders, Osteoporosis International, 22, 4, 2011. Crossref

  5. Onodera Yoshiaki, Miki Yasuhiro, Suzuki Takashi, Takagi Kiyoshi, Akahira Jun-ichi, Sakyu Takuya, Watanabe Mika, Inoue Satoshi, Ishida Takanori, Ohuchi Noriaki, Sasano Hironobu, Runx2 in human breast carcinoma: its potential roles in cancer progression, Cancer Science, 101, 12, 2010. Crossref

  6. Sun Merry, Iqbal Jameel, Singh Sukhjeet, Sun Li, Zaidi Mone, The crossover of bisphosphonates to cancer therapy, Annals of the New York Academy of Sciences, 1211, 1, 2010. Crossref

  7. Unnanuntana Aasis, Rebolledo Brian J., Khair Michael M., DiCarlo Edward F., Lane Joseph M., Diseases Affecting Bone Quality: Beyond Osteoporosis, Clinical Orthopaedics & Related Research, 469, 8, 2011. Crossref

  8. Willey Jeffrey S., Lloyd Shane A. J., Nelson Gregory A., Bateman Ted A., Ionizing Radiation and Bone Loss: Space Exploration and Clinical Therapy Applications, Clinical Reviews in Bone and Mineral Metabolism, 9, 1, 2011. Crossref

  9. Shirazi-Fard Yasaman, Alwood Joshua S., Schreurs Ann-Sofie, Castillo Alesha B., Globus Ruth K., Mechanical loading causes site-specific anabolic effects on bone following exposure to ionizing radiation, Bone, 81, 2015. Crossref

  10. Reuss-Borst M., Hartmann U., Scheede C., Weiß J., Prevalence of osteoporosis among cancer patients in Germany, Osteoporosis International, 23, 4, 2012. Crossref

  11. Gottwald L., Dukowicz A., Piekarski J., Misiewicz B., Spych M., Misiewicz P., Kazmierczak-Lukaszewicz S., Moszynska-Zielinska M., Cialkowska-Rysz A., Bone metastases from gynaecological epithelial cancers, Journal of Obstetrics and Gynaecology, 32, 1, 2012. Crossref

  12. YANG BING, TANG QUAN, POST JANINE, ZHOU HUI, HUANG XIAO-BIN, ZHANG XIAO-DONG, WANG QIN, SUN YUAN-MING, FAN FEI-YUE, Effect of radiation on the Notch signaling pathway in osteoblasts, International Journal of Molecular Medicine, 31, 3, 2013. Crossref

  13. Zylicz Zbigniew, Noncancer-Related Pain in Daily Practice, in Cancer Pain, 2013. Crossref

  14. Anisiewicz Artur, Filip-Psurska Beata, Pawlik Agata, Nasulewicz-Goldeman Anna, Piasecki Tomasz, Kowalski Konrad, Maciejewska Magdalena, Jarosz Joanna, Banach Joanna, Papiernik Diana, Mazur Andrzej, Kutner Andrzej, Maier Jeanette A, Wietrzyk Joanna, Calcitriol Analogues Decrease Lung Metastasis but Impair Bone Metabolism in Aged Ovariectomized Mice Bearing 4T1 Mammary Gland Tumours, Aging and disease, 10, 5, 2019. Crossref

  15. Soran Ozlem, Onco-Cardiology for Breast Cancer, in Breast Disease, 2019. Crossref

  16. Soran Ozlem, Onco-cardiology for Breast Cancer, in Breast Disease, 2016. Crossref

  17. Berent Taylor E., Dorschner Jessica M., Craig Theodore A., Drake Matthew T., Westendorf Jennifer J., Kumar Rajiv, Lung tumor cells inhibit bone mineralization and osteoblast activity, Biochemical and Biophysical Research Communications, 519, 3, 2019. Crossref

  18. Markes Martina, Exercise as an Intervention During Breast Cancer Treatment, in Exercise and Cancer Survivorship, 2010. Crossref

  19. Cianferotti Luisella, Bertoldo Francesco, Carini Marco, Kanis John A., Lapini Alberto, Longo Nicola, Martorana Giuseppe, Mirone Vincenzo, Reginster Jean-Yves, Rizzoli Rene, Brandi Maria Luisa, The prevention of fragility fractures in patients with non-metastatic prostate cancer: a position statement by the international osteoporosis foundation, Oncotarget, 8, 43, 2017. Crossref

  20. Wright Laura E., Harhash Ahmed A., Kozlow Wende M., Waning David L., Regan Jenna N., She Yun, John Sutha K., Murthy Sreemala, Niewolna Maryla, Marks Andrew R., Mohammad Khalid S., Guise Theresa A., Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo, Oncotarget, 8, 5, 2017. Crossref

  21. Santen R. J., Effect of Endocrine Therapies on Bone in Breast Cancer Patients, The Journal of Clinical Endocrinology & Metabolism, 96, 2, 2011. Crossref

  22. Xu Xiao-Long, Gou Wen-Long, Wang Ai-Yuan, Wang Yu, Guo Quan-Yi, Lu Qiang, Lu Shi-Bi, Peng Jiang, Basic research and clinical applications of bisphosphonates in bone disease: what have we learned over the last 40 years?, Journal of Translational Medicine, 11, 1, 2013. Crossref

  23. Tagawa Tomoko, Hurria Arti, Mortimer Joanne, Bone health maintenance in survivors of breast and prostate cancer, Aging Health, 5, 3, 2009. Crossref

  24. Alkhalil Abdulnaser, Clifford John, Miller Stacy Ann, Gautam Aarti, Jett Marti, Hammamieh Rasha, Moffatt Lauren T., Shupp Jeffrey W., Transcriptomics of Wet Skin Biopsies Predict Early Radiation-Induced Hematological Damage in a Mouse Model, Genes, 13, 3, 2022. Crossref

  25. Trivedi Trupti, Guise Theresa A., Systemic effects of abnormal bone resorption on muscle, metabolism, and cognition, Bone, 154, 2022. Crossref

  26. Pisarro Morena, Conti Francesco, Salute ossea in corso di trattamento adiuvante anti-ormonale nella patologia oncologica: rischio fratturativo e temporizzazione della terapia, L'Endocrinologo, 23, 4, 2022. Crossref

Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集 订购及政策 Begell House 联系我们 Language English 中文 Русский Português German French Spain